カテゴリー： Market Monitor Global, 世界, 医療/バイオ

インフルエンザRNAワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Flu RNA Vaccines Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5565）

◆商品コード：MMG23JU5565
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：77
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Flu RNA Vaccines Market 調査レポートは次の情報を含め、グローバルにおけるのインフルエンザRNAワクチン市場規模と予測を収録しています。・世界のインフルエンザRNAワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のインフルエンザRNAワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のインフルエンザRNAワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「非複製mRNA」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

インフルエンザRNAワクチンのグローバル主要企業は、Sanofi Pasteur Inc.、 AstraZeneca、 CSL Ltd.、 Abbott、 GlaxoSmithKline Plc.、 Serum Institute of India Pvt. Ltd.、 Pfizer、 BioNTech、 F.Hoffman La Roche Ltd、 Novartis、 Sinnovac Biotech Ltd、 Moderna Therapeutics、 CureVacなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、インフルエンザRNAワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のインフルエンザRNAワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のインフルエンザRNAワクチン市場：タイプ別市場シェア、2022年
・非複製mRNA、in vivo自己複製mRNA、in vitro樹状細胞非複製mRNAワクチン、その他

世界のインフルエンザRNAワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のインフルエンザRNAワクチン市場：用途別市場シェア、2022年
・病院、予防接種センター、専門クリニック、病院薬局、その他

世界のインフルエンザRNAワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のインフルエンザRNAワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるインフルエンザRNAワクチンのグローバル売上、2018年-2023年
・主要企業におけるインフルエンザRNAワクチンのグローバル売上シェア、2022年
・主要企業におけるインフルエンザRNAワクチンのグローバル販売量、2018年-2023年
・主要企業におけるインフルエンザRNAワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi Pasteur Inc.、 AstraZeneca、 CSL Ltd.、 Abbott、 GlaxoSmithKline Plc.、 Serum Institute of India Pvt. Ltd.、 Pfizer、 BioNTech、 F.Hoffman La Roche Ltd、 Novartis、 Sinnovac Biotech Ltd、 Moderna Therapeutics、 CureVac

*************************************************************

・調査・分析レポートの概要
インフルエンザRNAワクチン市場の定義
市場セグメント
世界のインフルエンザRNAワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のインフルエンザRNAワクチン市場規模
世界のインフルエンザRNAワクチン市場規模：2022年 VS 2029年
世界のインフルエンザRNAワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのインフルエンザRNAワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のインフルエンザRNAワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：非複製mRNA、in vivo自己複製mRNA、in vitro樹状細胞非複製mRNAワクチン、その他
インフルエンザRNAワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、予防接種センター、専門クリニック、病院薬局、その他
インフルエンザRNAワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別インフルエンザRNAワクチン市場規模 2022年と2029年
地域別インフルエンザRNAワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi Pasteur Inc.、 AstraZeneca、 CSL Ltd.、 Abbott、 GlaxoSmithKline Plc.、 Serum Institute of India Pvt. Ltd.、 Pfizer、 BioNTech、 F.Hoffman La Roche Ltd、 Novartis、 Sinnovac Biotech Ltd、 Moderna Therapeutics、 CureVac
...

The major advantage of Flu RNA Vaccines is that scientist need not to use the live cells for the vaccine preparation as such the RNA can be produced in the laboratory from a DNA template using readily available materials which can be a easy and fast weapon to fight against the new outbreaks and the existing infectious diseases.
This report aims to provide a comprehensive presentation of the global market for Flu RNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu RNA Vaccines. This report contains market size and forecasts of Flu RNA Vaccines in global, including the following market information:
Global Flu RNA Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Flu RNA Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Flu RNA Vaccines companies in 2022 (%)
The global Flu RNA Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Non-Replicating mRNA Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Flu RNA Vaccines include Sanofi Pasteur Inc., AstraZeneca, CSL Ltd., Abbott, GlaxoSmithKline Plc., Serum Institute of India Pvt. Ltd., Pfizer, BioNTech and F.Hoffman La Roche Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Flu RNA Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flu RNA Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, by Type, 2022 (%)
Non-Replicating mRNA
In Vivo Self-Replicating mRNA
In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
Others
Global Flu RNA Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospitals
Vaccination Center
Specialized Clinics
Hospital Pharmacy
Others
Global Flu RNA Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Flu RNA Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Flu RNA Vaccines revenues share in global market, 2022 (%)
Key companies Flu RNA Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Flu RNA Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Pasteur Inc.
AstraZeneca
CSL Ltd.
Abbott
GlaxoSmithKline Plc.
Serum Institute of India Pvt. Ltd.
Pfizer
BioNTech
F.Hoffman La Roche Ltd
Novartis
Sinnovac Biotech Ltd
Moderna Therapeutics
CureVac
Outline of Major Chapters:
Chapter 1: Introduces the definition of Flu RNA Vaccines, market overview.
Chapter 2: Global Flu RNA Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Flu RNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flu RNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Flu RNA Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Flu RNA Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Flu RNA Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Flu RNA Vaccines Overall Market Size
2.1 Global Flu RNA Vaccines Market Size: 2022 VS 2029
2.2 Global Flu RNA Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Flu RNA Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Flu RNA Vaccines Players in Global Market
3.2 Top Global Flu RNA Vaccines Companies Ranked by Revenue
3.3 Global Flu RNA Vaccines Revenue by Companies
3.4 Global Flu RNA Vaccines Sales by Companies
3.5 Global Flu RNA Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Flu RNA Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Flu RNA Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Flu RNA Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Flu RNA Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Flu RNA Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Flu RNA Vaccines Market Size Markets, 2022 & 2029
4.1.2 Non-Replicating mRNA
4.1.3 In Vivo Self-Replicating mRNA
4.1.4 In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
4.1.5 Others
4.2 By Type – Global Flu RNA Vaccines Revenue & Forecasts
4.2.1 By Type – Global Flu RNA Vaccines Revenue, 2018-2023
4.2.2 By Type – Global Flu RNA Vaccines Revenue, 2024-2029
4.2.3 By Type – Global Flu RNA Vaccines Revenue Market Share, 2018-2029
4.3 By Type – Global Flu RNA Vaccines Sales & Forecasts
4.3.1 By Type – Global Flu RNA Vaccines Sales, 2018-2023
4.3.2 By Type – Global Flu RNA Vaccines Sales, 2024-2029
4.3.3 By Type – Global Flu RNA Vaccines Sales Market Share, 2018-2029
4.4 By Type – Global Flu RNA Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Flu RNA Vaccines Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Vaccination Center
5.1.4 Specialized Clinics
5.1.5 Hospital Pharmacy
5.1.6 Others
5.2 By Application – Global Flu RNA Vaccines Revenue & Forecasts
5.2.1 By Application – Global Flu RNA Vaccines Revenue, 2018-2023
5.2.2 By Application – Global Flu RNA Vaccines Revenue, 2024-2029
5.2.3 By Application – Global Flu RNA Vaccines Revenue Market Share, 2018-2029
5.3 By Application – Global Flu RNA Vaccines Sales & Forecasts
5.3.1 By Application – Global Flu RNA Vaccines Sales, 2018-2023
5.3.2 By Application – Global Flu RNA Vaccines Sales, 2024-2029
5.3.3 By Application – Global Flu RNA Vaccines Sales Market Share, 2018-2029
5.4 By Application – Global Flu RNA Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Flu RNA Vaccines Market Size, 2022 & 2029
6.2 By Region – Global Flu RNA Vaccines Revenue & Forecasts
6.2.1 By Region – Global Flu RNA Vaccines Revenue, 2018-2023
6.2.2 By Region – Global Flu RNA Vaccines Revenue, 2024-2029
6.2.3 By Region – Global Flu RNA Vaccines Revenue Market Share, 2018-2029
6.3 By Region – Global Flu RNA Vaccines Sales & Forecasts
6.3.1 By Region – Global Flu RNA Vaccines Sales, 2018-2023
6.3.2 By Region – Global Flu RNA Vaccines Sales, 2024-2029
6.3.3 By Region – Global Flu RNA Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Flu RNA Vaccines Revenue, 2018-2029
6.4.2 By Country – North America Flu RNA Vaccines Sales, 2018-2029
6.4.3 US Flu RNA Vaccines Market Size, 2018-2029
6.4.4 Canada Flu RNA Vaccines Market Size, 2018-2029
6.4.5 Mexico Flu RNA Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Flu RNA Vaccines Revenue, 2018-2029
6.5.2 By Country – Europe Flu RNA Vaccines Sales, 2018-2029
6.5.3 Germany Flu RNA Vaccines Market Size, 2018-2029
6.5.4 France Flu RNA Vaccines Market Size, 2018-2029
6.5.5 U.K. Flu RNA Vaccines Market Size, 2018-2029
6.5.6 Italy Flu RNA Vaccines Market Size, 2018-2029
6.5.7 Russia Flu RNA Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Flu RNA Vaccines Market Size, 2018-2029
6.5.9 Benelux Flu RNA Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Flu RNA Vaccines Revenue, 2018-2029
6.6.2 By Region – Asia Flu RNA Vaccines Sales, 2018-2029
6.6.3 China Flu RNA Vaccines Market Size, 2018-2029
6.6.4 Japan Flu RNA Vaccines Market Size, 2018-2029
6.6.5 South Korea Flu RNA Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Flu RNA Vaccines Market Size, 2018-2029
6.6.7 India Flu RNA Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Flu RNA Vaccines Revenue, 2018-2029
6.7.2 By Country – South America Flu RNA Vaccines Sales, 2018-2029
6.7.3 Brazil Flu RNA Vaccines Market Size, 2018-2029
6.7.4 Argentina Flu RNA Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Flu RNA Vaccines Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Flu RNA Vaccines Sales, 2018-2029
6.8.3 Turkey Flu RNA Vaccines Market Size, 2018-2029
6.8.4 Israel Flu RNA Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Flu RNA Vaccines Market Size, 2018-2029
6.8.6 UAE Flu RNA Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi Pasteur Inc.
7.1.1 Sanofi Pasteur Inc. Company Summary
7.1.2 Sanofi Pasteur Inc. Business Overview
7.1.3 Sanofi Pasteur Inc. Flu RNA Vaccines Major Product Offerings
7.1.4 Sanofi Pasteur Inc. Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Pasteur Inc. Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Flu RNA Vaccines Major Product Offerings
7.2.4 AstraZeneca Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 CSL Ltd.
7.3.1 CSL Ltd. Company Summary
7.3.2 CSL Ltd. Business Overview
7.3.3 CSL Ltd. Flu RNA Vaccines Major Product Offerings
7.3.4 CSL Ltd. Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 CSL Ltd. Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Flu RNA Vaccines Major Product Offerings
7.4.4 Abbott Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 GlaxoSmithKline Plc.
7.5.1 GlaxoSmithKline Plc. Company Summary
7.5.2 GlaxoSmithKline Plc. Business Overview
7.5.3 GlaxoSmithKline Plc. Flu RNA Vaccines Major Product Offerings
7.5.4 GlaxoSmithKline Plc. Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Plc. Key News & Latest Developments
7.6 Serum Institute of India Pvt. Ltd.
7.6.1 Serum Institute of India Pvt. Ltd. Company Summary
7.6.2 Serum Institute of India Pvt. Ltd. Business Overview
7.6.3 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Major Product Offerings
7.6.4 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Serum Institute of India Pvt. Ltd. Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Flu RNA Vaccines Major Product Offerings
7.7.4 Pfizer Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 BioNTech
7.8.1 BioNTech Company Summary
7.8.2 BioNTech Business Overview
7.8.3 BioNTech Flu RNA Vaccines Major Product Offerings
7.8.4 BioNTech Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 BioNTech Key News & Latest Developments
7.9 F.Hoffman La Roche Ltd
7.9.1 F.Hoffman La Roche Ltd Company Summary
7.9.2 F.Hoffman La Roche Ltd Business Overview
7.9.3 F.Hoffman La Roche Ltd Flu RNA Vaccines Major Product Offerings
7.9.4 F.Hoffman La Roche Ltd Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 F.Hoffman La Roche Ltd Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Flu RNA Vaccines Major Product Offerings
7.10.4 Novartis Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Sinnovac Biotech Ltd
7.11.1 Sinnovac Biotech Ltd Company Summary
7.11.2 Sinnovac Biotech Ltd Flu RNA Vaccines Business Overview
7.11.3 Sinnovac Biotech Ltd Flu RNA Vaccines Major Product Offerings
7.11.4 Sinnovac Biotech Ltd Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 Sinnovac Biotech Ltd Key News & Latest Developments
7.12 Moderna Therapeutics
7.12.1 Moderna Therapeutics Company Summary
7.12.2 Moderna Therapeutics Flu RNA Vaccines Business Overview
7.12.3 Moderna Therapeutics Flu RNA Vaccines Major Product Offerings
7.12.4 Moderna Therapeutics Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Moderna Therapeutics Key News & Latest Developments
7.13 CureVac
7.13.1 CureVac Company Summary
7.13.2 CureVac Flu RNA Vaccines Business Overview
7.13.3 CureVac Flu RNA Vaccines Major Product Offerings
7.13.4 CureVac Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 CureVac Key News & Latest Developments
8 Global Flu RNA Vaccines Production Capacity, Analysis
8.1 Global Flu RNA Vaccines Production Capacity, 2018-2029
8.2 Flu RNA Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Flu RNA Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Flu RNA Vaccines Supply Chain Analysis
10.1 Flu RNA Vaccines Industry Value Chain
10.2 Flu RNA Vaccines Upstream Market
10.3 Flu RNA Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Flu RNA Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Flu RNA Vaccines in Global Market
Table 2. Top Flu RNA Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Flu RNA Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Flu RNA Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Flu RNA Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Flu RNA Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Flu RNA Vaccines Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Flu RNA Vaccines Product Type
Table 9. List of Global Tier 1 Flu RNA Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Flu RNA Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Flu RNA Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Flu RNA Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Flu RNA Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Flu RNA Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Flu RNA Vaccines Sales (K Units), 2024-2029
Table 16. By Application – Global Flu RNA Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Flu RNA Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Flu RNA Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Flu RNA Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Flu RNA Vaccines Sales (K Units), 2024-2029
Table 21. By Region – Global Flu RNA Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Flu RNA Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Flu RNA Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Flu RNA Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Flu RNA Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Flu RNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Flu RNA Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Flu RNA Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Flu RNA Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Flu RNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Flu RNA Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Flu RNA Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Flu RNA Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Flu RNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Flu RNA Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Flu RNA Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Flu RNA Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Flu RNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Flu RNA Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Flu RNA Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Flu RNA Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Flu RNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Flu RNA Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Flu RNA Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Flu RNA Vaccines Sales, (K Units), 2024-2029
Table 46. Sanofi Pasteur Inc. Company Summary
Table 47. Sanofi Pasteur Inc. Flu RNA Vaccines Product Offerings
Table 48. Sanofi Pasteur Inc. Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi Pasteur Inc. Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Flu RNA Vaccines Product Offerings
Table 52. AstraZeneca Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. CSL Ltd. Company Summary
Table 55. CSL Ltd. Flu RNA Vaccines Product Offerings
Table 56. CSL Ltd. Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. CSL Ltd. Key News & Latest Developments
Table 58. Abbott Company Summary
Table 59. Abbott Flu RNA Vaccines Product Offerings
Table 60. Abbott Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Abbott Key News & Latest Developments
Table 62. GlaxoSmithKline Plc. Company Summary
Table 63. GlaxoSmithKline Plc. Flu RNA Vaccines Product Offerings
Table 64. GlaxoSmithKline Plc. Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. GlaxoSmithKline Plc. Key News & Latest Developments
Table 66. Serum Institute of India Pvt. Ltd. Company Summary
Table 67. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Offerings
Table 68. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Serum Institute of India Pvt. Ltd. Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Flu RNA Vaccines Product Offerings
Table 72. Pfizer Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. BioNTech Company Summary
Table 75. BioNTech Flu RNA Vaccines Product Offerings
Table 76. BioNTech Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. BioNTech Key News & Latest Developments
Table 78. F.Hoffman La Roche Ltd Company Summary
Table 79. F.Hoffman La Roche Ltd Flu RNA Vaccines Product Offerings
Table 80. F.Hoffman La Roche Ltd Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. F.Hoffman La Roche Ltd Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Flu RNA Vaccines Product Offerings
Table 84. Novartis Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Sinnovac Biotech Ltd Company Summary
Table 87. Sinnovac Biotech Ltd Flu RNA Vaccines Product Offerings
Table 88. Sinnovac Biotech Ltd Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Sinnovac Biotech Ltd Key News & Latest Developments
Table 90. Moderna Therapeutics Company Summary
Table 91. Moderna Therapeutics Flu RNA Vaccines Product Offerings
Table 92. Moderna Therapeutics Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Moderna Therapeutics Key News & Latest Developments
Table 94. CureVac Company Summary
Table 95. CureVac Flu RNA Vaccines Product Offerings
Table 96. CureVac Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. CureVac Key News & Latest Developments
Table 98. Flu RNA Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Flu RNA Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Flu RNA Vaccines Production by Region, 2018-2023 (K Units)
Table 101. Global Flu RNA Vaccines Production by Region, 2024-2029 (K Units)
Table 102. Flu RNA Vaccines Market Opportunities & Trends in Global Market
Table 103. Flu RNA Vaccines Market Drivers in Global Market
Table 104. Flu RNA Vaccines Market Restraints in Global Market
Table 105. Flu RNA Vaccines Raw Materials
Table 106. Flu RNA Vaccines Raw Materials Suppliers in Global Market
Table 107. Typical Flu RNA Vaccines Downstream
Table 108. Flu RNA Vaccines Downstream Clients in Global Market
Table 109. Flu RNA Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Flu RNA Vaccines Segment by Type in 2022
Figure 2. Flu RNA Vaccines Segment by Application in 2022
Figure 3. Global Flu RNA Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Flu RNA Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Flu RNA Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Flu RNA Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Flu RNA Vaccines Revenue in 2022
Figure 9. By Type - Global Flu RNA Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Flu RNA Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Flu RNA Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Flu RNA Vaccines Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Flu RNA Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Flu RNA Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Flu RNA Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Flu RNA Vaccines Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Flu RNA Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Flu RNA Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Flu RNA Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Flu RNA Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Flu RNA Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Flu RNA Vaccines Sales Market Share, 2018-2029
Figure 23. US Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Flu RNA Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Flu RNA Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Flu RNA Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Flu RNA Vaccines Sales Market Share, 2018-2029
Figure 37. China Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Flu RNA Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Flu RNA Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Flu RNA Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Flu RNA Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Flu RNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Flu RNA Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Flu RNA Vaccines by Region, 2022 VS 2029
Figure 54. Flu RNA Vaccines Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ インフルエンザRNAワクチンの世界市場見通し2023年-2029年(Flu RNA Vaccines Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

インフルエンザRNAワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp